Synthesis and antitumor activity of biotinylated camptothecin derivatives as potent cytotoxic agents

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• Camptothecin derivatives are known for their anticancer properties.
• Developing novel anticancer agents with improved efficacy and reduced toxicity is a continuous goal in cancer research.
• Biotinylation can modify drug properties and targeting capabilities.

Purpose of the Study:

• To design and synthesize novel biotinylated camptothecin derivatives.
• To evaluate the in vitro cytotoxicity of these new compounds against a panel of human tumor cell lines.
• To investigate the structure-activity relationships (SARs) of these derivatives to guide the development of new anticancer drugs.

Main Methods:

• Synthesis of biotinylated camptothecin derivatives utilizing esterification and click chemistry.
• Cytotoxicity assays performed on five human tumor cell lines: HL-60, SMMC-7721, A-549, MCF-7, and SW480.
• Determination of half-maximal inhibitory concentration (IC50) values for all synthesized compounds.

Main Results:

• Successful synthesis of a series of biotinylated camptothecin derivatives.
• Most derivatives exhibited potent cytotoxicity, with IC50 values ranging from 0.13 to 21.53 μM.
• Compounds 17 and 18 displayed the highest potencies, with IC50 values as low as 0.13 μM and 0.23 μM, respectively.

Conclusions:

• The synthesized biotinylated camptothecin derivatives possess significant anticancer potential.
• Compounds 17 and 18 are promising candidates for further investigation as anticancer agents.
• The SAR analysis provides valuable insights for the rational design of future camptothecin-based therapeutics.